CytoDyn to Attend BIOCOM Global Life Sciences Partnering Conference
2/27/2013 7:39:49 AM
More...
|
CytoDyn Announces Collaboration With Dr. Bruce Torbett, The Scripps Research Institute, to Study PRO 140 in a Pre-exposure Prophylaxis (PrEP) Model of HIV Infection
2/26/2013 10:08:05 AM
More...
|
CytoDyn to Attend 31st Annual J.P. Morgan Healthcare Conference
1/7/2013 6:25:52 AM
More...
|
CytoDyn Announces Phase IIB Clinical Trial Agreement With Dr. Jeffrey Jacobson, Drexel University
11/19/2012 9:54:48 AM
More...
|
CytoDyn Moves Corporate Headquarters to Oregon
10/29/2012 6:51:48 AM
More...
|
CytoDyn Announces Acquisition of Pro 140
10/17/2012 9:58:15 AM
More...
|
CytoDyn to Present Findings on Its Feline Immunodeficiency Virus (FIV) Therapeutic Antibody Program
10/5/2012 9:57:58 AM
More...
|
CytoDyn Retains Gibraltar Associates for Corporate and Investor Communications
10/3/2012 10:00:22 AM
More...
|
CytoDyn Names Dr. Nader Pourhassan New CEO
9/12/2012 6:50:45 AM
More...
|
CytoDyn Announces Management Update Conference Call on Thursday, August 23
8/22/2012 9:39:12 AM
More...
|
|